Condition: Peritoneal Carcinomatosis · Sponsor: Fondazione del Piemonte per l'Oncologia
This prospective multicenter interventional pre-post study aims to evaluate the effect of implementing an Enhanced Recovery After Surgery (ERAS) protocol in patients with peritoneal carcinomatosis undergoing cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC). Approximately 300 patients will be enrolled across 20 Italian centers. During an initial pre-intervention period, usual perioperative management will be described; during a subsequent intervention period, participating centers will apply a predefined ERAS protocol. The primary objective is to assess the effect of ERAS implementation on mean postoperative hospital length of stay.
This description comes directly from the study's public registry record.
Manuela Robella, MD · +390119933445 · manuela.robella@ircc.it
Always discuss trial participation with your own doctor first.
| Fondazione del Piemonte per l'Oncologia- IRCCS Istituto di Candiolo | Candiolo, Turin, Italy | Recruiting |
| Fondazione IRCCS Policlinico San Matteo | Pavia, Italy | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07493876